Results 61 to 70 of about 1,698,554 (189)

Artificial intelligence empowers targeted protein degradation: Core technological innovations, multi‐scenario applications, and translational prospects

open access: yesSmart Molecules, EarlyView.
AI is transforming TPD by improving the design, prediction, and optimization of degraders such as PROTACs, molecular glues, and LYTACs. This review summarizes key AI‐driven advances, highlights applications across drug discovery stages, and discusses remaining challenges and future directions for accelerating the development of therapies against ...
Shuanglin Qin   +10 more
wiley   +1 more source

Estudos de QSAR 3D para um conjunto de inibidores de butirilcolinesterase humana QSAR 3D studies of a series of human butyrylcholinesterase inhibitors

open access: yesQuímica Nova, 2009
Alzheimer's disease (AD) is considered the main cause of cognitive decline in adults. The available therapies for AD treatment seek to maintain the activity of cholinergic system through the inhibition of the enzyme acetylcholinesterase.
Humberto F. Freitas   +2 more
doaj   +1 more source

Assessment of machine learning reliability methods for quantifying the applicability domain of QSAR regression models [PDF]

open access: yes, 2014
The vastness of chemical space and the relatively small coverage by experimental data recording molecular properties require us to identify subspaces, or domains, for which we can confidently apply QSAR models.
Polajnar, Matija   +18 more
core   +1 more source

An Interpretable Machine‐Learning Framework for Multi‐Endpoint Drug‐Induced Liver Injury Classification: Evaluating the Contribution of Molecular Structure

open access: yesAdvanced Computing, Volume 1, Issue 1, December 2026.
Molecular structure provides a complementary perspective on drug‐induced liver injury. Integrating 801 drugs across five DILI endpoints, our interpretable AI framework reveals endpoint‐dependent structural contributions and links predictive classification with molecular‐level interpretation, highlighting the complex interplay between clinical ...
Priya Kumari, Kunal Roy, Madhulika Gupta
wiley   +1 more source

Structure-activity relationship revealed by 3D-QSAR and docking studies.

open access: yes, 2014
Structure-activity relationship revealed by 3D-QSAR and docking studies.
Gaokeng Xiao (550476)   +7 more
core   +1 more source

Optimisation of Topical and Transdermal Pharmaceutical Formulations: Methods, Challenges and Opportunities

open access: yesSmartSys, Volume 2, Issue 4, December 2026.
ABSTRACT Topical and transdermal pharmaceutical formulations are a large and diverse class of products, yet their optimisation remains a complex, resource‐intensive challenge. Statistical design‐of‐experiments approaches have long provided the methodological backbone for this process and have shown broad effectiveness across topical and transdermal ...
Yongrui Xiao   +5 more
wiley   +1 more source

Pharmacophore Modeling and 3D QSAR analysis of flavonoids and congeners active against A549 cell line

open access: yesInternational Journal of Research in Pharmaceutical Sciences, 2012
In our present study we have developed a ligand based 3D QSAR of 27 flavonoids and congeners active against human lung cancer cell line (A549) using the Phase module of Schrödinger suit.
Sudhan Debnath*   +3 more
doaj  

3D QSAR, pharmacophore indentification studies on series of 1-(2-ethoxyethyl)-1H-pyrazolo [4,3-d]pyrimidines as phosphodiesterase V inhibitors

open access: yesJournal of Saudi Chemical Society, 2015
Context: In recent years phosphodiesterase V acts as an attractive target for cardiovascular drug design and QSAR techniques are helpful for the optimization of structural requirements for designing novel compounds.
Prafulla Choudhari, Manish Bhatia
doaj   +1 more source

Evaluating Thiram‐Induced Embryotoxicity Using Integrated In Silico, In Vitro, and Transcriptomic Approaches

open access: yesEnvironmental Toxicology, Volume 41, Issue 12, Page 1798-1812, December 2026.
ABSTRACT Long‐term exposure to low‐dose food contact materials (FCMs) has raised concerns regarding developmental toxicity. In the present study, we prioritized FCMs with potential developmental toxicity using a weight‐of‐evidence computational model, which predicted 127 chemicals to be of high concern.
Chia‐Chi Ho   +7 more
wiley   +1 more source

Drug Design and Discovery: The Long Road From Hansch Analysis to Artificial Intelligence

open access: yesChemMedChem, Volume 21, Issue 21, 12 November 2026.
The evolution of quantitative structure–activity relationships (QSAR) is traced from the pioneering work of Hansch to its contemporary applications in drug discovery. Key developments in multidimensional QSAR, multivariate statistical analysis and machine learning, model validation, and multi‐objective optimization are discussed.
Anna Tsantili‐Kakoulidou
wiley   +1 more source

Home - About - Disclaimer - Privacy